James C. Fang, MD, FACC

James Fang, MD, FACC

General Statement of Disclosure:

OFFICER, DIRECTOR ETC: HFSA(NONE) RESEARCH/RESEARCH GRANTS: National Institutes of Health(MODEST) OTHER FINANCIAL BENEFIT: Amgen Inc.(MODEST), AHA(MODEST), AstraZeneca Pharmaceuticals(MODEST), National Institutes of Health(MODEST), National Institutes of Health(MODEST), Novartis Corporation(SIGNIFICANT), AHA(SIGNIFICANT), ACI Clinical(SIGNIFICANT), UpToDate(MODEST), National Institutes of Health(NONE), National Institutes of Health(NONE), Sardocor(MODEST)

View Full Disclosure